{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T07:03:53Z","timestamp":1785308633080,"version":"3.55.0"},"reference-count":116,"publisher":"Baskent University","issue":"Supp 2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Clin Transplant"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.6002\/ect.mesot2025.o25","type":"journal-issue","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T10:22:48Z","timestamp":1785234168000},"source":"Crossref","is-referenced-by-count":0,"title":[],"prefix":"10.6002","volume":"24","member":"4021","reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1136\/gutjnl-2012-304269","article-title":"Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review","volume":"63","author":"El-Serag","year":"2014","unstructured":"1. El-Serag HB, Sweet S, Winchester CC, Dent J. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2014;63:871-880.","journal-title":"Gut"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1111\/j.1572-0241.2006.00630.x","article-title":"The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus","volume":"101","author":"Vakil","year":"2006","unstructured":"2. Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R; Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006;101:1900-1920.","journal-title":"Am J Gastroenterol"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. de Bortoli N, Martinucci I, Savarino E, et al. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they? Neurogastroenterol Motil 2014;26:28-35.","DOI":"10.1111\/nmo.12221"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1136\/gutjnl-2017-314722","article-title":"Modern diagnosis of GERD: the Lyon consensus","volume":"67","author":"Gyawali","year":"2018","unstructured":"4. Gyawali CP, Kahrilas PJ, Savarino E, et al. Modern diagnosis of GERD: the Lyon consensus. Gut 2018;67:1351-1362.","journal-title":"Gut"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1136\/gutjnl-2023-330616","article-title":"0","volume":"73","author":"Gyawali","year":"2024","unstructured":"5. Gyawali CP, Yadlapati R, Fass R, et al. Updates to the modern diagnosis of GERD: Lyon consensus 2.0. Gut 2024;73:361-371.","journal-title":"Gut"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1053\/j.gastro.2016.03.035","article-title":"Rome IV-functional GI disorders: disorders of gut-brain interaction","volume":"150","author":"DA","year":"2016","unstructured":"6. Drossman DA, Hasler WL. Rome IV-functional GI disorders: disorders of gut-brain interaction. Gastroenterology 2016;150:1257-1261.","journal-title":"Gastroenterology"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. Drossman DA. Functional gastrointestinal disorders: history, pathophysiology, clinical features, and Rome IV. Gastroenterology 2016;150:1262-1279.e2.","DOI":"10.1053\/j.gastro.2016.02.032"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Guadagnoli L, Yadlapati R, Taft T, Pandolfino JE, Tye M, Keefer L. Esophageal hypervigilance is prevalent across gastroesophageal reflux disease presentations. Neurogastroenterol Motil 2021;33: e14081.","DOI":"10.1111\/nmo.14081"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1053\/j.gastro.2026.02.005","article-title":"Functional esophageal disorders","volume":"170","author":"Gyawali","year":"2026","unstructured":"9. Gyawali CP, Roman S, Zerbib F, et al. Functional esophageal disorders. Gastroenterology 2026;170:1224-1239.","journal-title":"Gastroenterology"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.cgh.2019.07.015","article-title":"Phenotypes of gastroesophageal reflux disease: where Rome, Lyon, and Montreal meet","volume":"18","author":"Katzka","year":"2020","unstructured":"10. Katzka DA, Pandolfino JE, Kahrilas PJ. Phenotypes of gastroesophageal reflux disease: where Rome, Lyon, and Montreal meet. Clin Gastroenterol Hepatol 2020;18:767-776.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1159\/000080308","article-title":"Review of the quality of life and burden of illness in gastroesophageal reflux disease","volume":"22","author":"Wiklund","year":"2004","unstructured":"11. Wiklund I. Review of the quality of life and burden of illness in gastroesophageal reflux disease. Dig Dis 2004;22:108-114.","journal-title":"Dig Dis"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/j.1572-0241.2005.00343.x","article-title":"Gastroesophageal reflux symptoms and well-being in a random sample of the general population of a Swedish community","volume":"101","author":"Wiklund","year":"2006","unstructured":"12. Wiklund I, Carlsson J, Vakil N. Gastroesophageal reflux symptoms and well-being in a random sample of the general population of a Swedish community. Am J Gastroenterol 2006;101:18-28.","journal-title":"Am J Gastroenterol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.14309\/ajg.0000000000003467","article-title":"Patient-reported outcome measures in benign esophageal disorders","volume":"120","author":"Pandolfino","year":"2025","unstructured":"13. Pandolfino JE, Fass R, Chan WW, Gyawali CP. Patient-reported outcome measures in benign esophageal disorders. Am J Gastroenterol 2025;120:1699-1707.","journal-title":"Am J Gastroenterol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1111\/j.1365-2036.2009.04142.x","article-title":"Development of the GerdQ, a tool for the diagnosis and management of gastro-oesophageal reflux disease in primary care","volume":"30","author":"Jones","year":"2009","unstructured":"14. Jones R, Junghard O, Dent J, et al. Development of the GerdQ, a tool for the diagnosis and management of gastro-oesophageal reflux disease in primary care. Aliment Pharmacol Ther 2009;30: 1030-1038.","journal-title":"Aliment Pharmacol Ther"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.14309\/ajg.0000000000003499","article-title":"Validation of esophageal global symptom severity as a patient-reported outcome for evaluation of reflux symptoms","volume":"120","author":"Chan","year":"2025","unstructured":"15. Chan WW, Schroeder M, Richardson A, et al. Validation of esophageal global symptom severity as a patient-reported outcome for evaluation of reflux symptoms. Am J Gastroenterol 2025;120: 1760-1769.","journal-title":"Am J Gastroenterol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41575-023-00883-z","article-title":"Pathophysiology of gastro-oesophageal reflux disease: implications for diagnosis and management","volume":"21","author":"Arg\u00fcero J","year":"2024","unstructured":"16. Arg\u00fcero J, Sifrim D. Pathophysiology of gastro-oesophageal reflux disease: implications for diagnosis and management. Nat Rev Gastroenterol Hepatol 2024;21:282-293.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"518","DOI":"10.7326\/0003-4819-140-7-200404060-00011","article-title":"Short-term treatment with proton-pump inhibitors as a test for gastroesophageal reflux disease: a meta-analysis of diagnostic test characteristics","volume":"140","author":"Numans","year":"2004","unstructured":"17. Numans ME, Lau J, de Wit NJ, Bonis PA. Short-term treatment with proton-pump inhibitors as a test for gastroesophageal reflux disease: a meta-analysis of diagnostic test characteristics. Ann Intern Med 2004;140:518-527.","journal-title":"Ann Intern Med"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18. Sigterman KE, van Pinxteren B, Bonis PA, Lau J, Numans ME. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease. Cochrane Database Syst Rev 2013;2013:CD002095.","DOI":"10.1002\/14651858.CD002095.pub5"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1136\/gutjnl-2013-304883","article-title":"Impact of regurgitation on health-related quality of life in gastro-oesophageal reflux disease before and after shortterm potent acid suppression therapy","volume":"63","author":"Kahrilas","year":"2014","unstructured":"19. Kahrilas PJ, Jonsson A, Denison H, Wernersson B, Hughes N, Howden CW. Impact of regurgitation on health-related quality of life in gastro-oesophageal reflux disease before and after shortterm potent acid suppression therapy. Gut 2014;63:720-726.","journal-title":"Gut"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1111\/apt.12298","article-title":"Impact of persistent, frequent regurgitation on quality of life in heartburn responders treated with acid suppression: a multinational primary care study","volume":"37","author":"Kahrilas","year":"2013","unstructured":"20. Kahrilas PJ, Howden CW, Wernersson B, Denison H, Nuevo J, Gisbert JP. Impact of persistent, frequent regurgitation on quality of life in heartburn responders treated with acid suppression: a multinational primary care study. Aliment Pharmacol Ther 2013; 37:1005-1010.","journal-title":"Aliment Pharmacol Ther"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1038\/ajg.2011.146","article-title":"Response of regurgitation to proton pump inhibitor therapy in clinical trials of gastroesophageal reflux disease","volume":"106","author":"Kahrilas","year":"2011","unstructured":"21. Kahrilas PJ, Howden CW, Hughes N. Response of regurgitation to proton pump inhibitor therapy in clinical trials of gastroesophageal reflux disease. Am J Gastroenterol 2011;106:1419-1425.","journal-title":"Am J Gastroenterol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1136\/gut.2011.241307","article-title":"Response of unexplained chest pain to proton pump inhibitor treatment in patients with and without objective evidence of gastro-oesophageal reflux disease","volume":"60","author":"Kahrilas","year":"2011","unstructured":"22. Kahrilas PJ, Hughes N, Howden CW. Response of unexplained chest pain to proton pump inhibitor treatment in patients with and without objective evidence of gastro-oesophageal reflux disease. Gut 2011;60:1473-1478.","journal-title":"Gut"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1111\/j.1572-0241.2005.41657.x","article-title":"Diagnostic and therapeutic use of proton pump inhibitors in non-cardiac chest pain: a metaanalysis","volume":"100","author":"Cremonini","year":"2005","unstructured":"23. Cremonini F, Wise J, Moayyedi P, Talley NJ. Diagnostic and therapeutic use of proton pump inhibitors in non-cardiac chest pain: a metaanalysis. Am J Gastroenterol 2005;100:1226-1232.","journal-title":"Am J Gastroenterol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"27","DOI":"10.14309\/ajg.0000000000001538","article-title":"ACG clinical guideline for the diagnosis and management of gastroesophageal reflux disease","volume":"117","author":"Katz","year":"2022","unstructured":"24. Katz PO, Dunbar KB, Schnoll-Sussman FH, Greer KB, Yadlapati R, Spechler SJ. ACG clinical guideline for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol 2022;117:27-56.","journal-title":"Am J Gastroenterol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"322","DOI":"10.14309\/ajg.0000000000003482","article-title":"The San Diego consensus for laryngopharyngeal symptoms and laryngopharyngeal reflux disease","volume":"121","author":"Yadlapati","year":"2026","unstructured":"25. Yadlapati R, Weissbrod P, Walsh E, et al. The San Diego consensus for laryngopharyngeal symptoms and laryngopharyngeal reflux disease. Am J Gastroenterol 2026;121:322-336.","journal-title":"Am J Gastroenterol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1001\/jamaoto.2013.6533","article-title":"Hoarseness and laryngopharyngeal reflux: a survey of primary care physician practice patterns","volume":"140","author":"Ruiz","year":"2014","unstructured":"26. Ruiz R, Jeswani S, Andrews K, et al. Hoarseness and laryngopharyngeal reflux: a survey of primary care physician practice patterns. JAMA Otolaryngol Head Neck Surg 2014;140:192-196.","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"27. Chen JW, Vela MF, Peterson KA, Carlson DA. AGA clinical practice update on the diagnosis and management of extraesophageal gastroesophageal reflux disease: expert review. Clin Gastroenterol Hepatol 2023;21:1414-1421, e3.","DOI":"10.1016\/j.cgh.2023.01.040"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"28. Chang AB, Lasserson TJ, Gaffney J, Connor FL, Garske LA. Gastro-oesophageal reflux treatment for prolonged non-specific cough in children and adults. Cochrane Database Syst Rev 2011; 2011:CD004823.","DOI":"10.1002\/14651858.CD004823.pub4"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1177\/014556131309200811","article-title":"A systematic review of proton-pump inhibitor therapy for laryngopharyngeal reflux","volume":"92","author":"Megwalu","year":"2013","unstructured":"29. Megwalu UC. A systematic review of proton-pump inhibitor therapy for laryngopharyngeal reflux. Ear Nose Throat J 2013;92:364-371.","journal-title":"Ear Nose Throat J"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"627","DOI":"10.14309\/ajg.0000000000002557","article-title":"Diagnostic yield of ambulatory reflux monitoring systems for evaluation of chronic laryngeal symptoms","volume":"119","author":"Krause","year":"2024","unstructured":"30. Krause AJ, Greytak M, Kaizer AM, et al. Diagnostic yield of ambulatory reflux monitoring systems for evaluation of chronic laryngeal symptoms. Am J Gastroenterol 2024;119:627-634.","journal-title":"Am J Gastroenterol"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"31. Shah ED, Yadlapati R, Chan WW, Gyawali CP. Optimizing evaluation of gastroesophageal reflux with atypical symptoms: cost-effectiveness and cost-minimalization analysis. Clin Gastroenterol Hepatol Published Online First: 24 Nov 2025. doi:10.1016\/j. cgh.2025.11.014.","DOI":"10.1016\/j.cgh.2025.11.014"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"32. Krause AJ, Kaizer AM, Carlson DA, et al. Validated clinical score to predict gastroesophageal reflux in patients with chronic laryngeal symptoms: COuGH RefluX. Clin Gastroenterol Hepatol 2024;22:1200-1209, e1.","DOI":"10.1016\/j.cgh.2024.01.021"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1038\/ajg.2014.165","article-title":"The pathophysiology, diagnosis and treatment of excessive belching symptoms","volume":"109","author":"Kessing","year":"2014","unstructured":"33. Kessing BF, Bredenoord AJ, Smout AJ. The pathophysiology, diagnosis and treatment of excessive belching symptoms. Am J Gastroenterol 2014;109:1196-1203.","journal-title":"Am J Gastroenterol"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"34. Rengarajan A, Pomarat M, Zerbib F, Gyawali CP. Overlap of functional heartburn and reflux hypersensitivity with proven gastroesophageal reflux disease. Neurogastroenterol Motil 2021;33: e14056.","DOI":"10.1111\/nmo.14056"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"35. Yadlapati R, Gyawali CP, Pandolfino JE; CGIT GERD Consensus Conference Participants. AGA clinical practice update on the personalized approach to the evaluation and management of GERD: expert review. Clin Gastroenterol Hepatol 2022;20:984-994, e1.","DOI":"10.1016\/j.cgh.2022.01.025"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.gie.2009.08.024","article-title":"Upper GI tract findings in patients with heartburn in whom proton pump inhibitor treatment failed versus those not receiving antireflux treatment","volume":"71","author":"Poh","year":"2010","unstructured":"36. Poh CH, Gasiorowska A, Navarro-Rodriguez T, et al. Upper GI tract findings in patients with heartburn in whom proton pump inhibitor treatment failed versus those not receiving antireflux treatment. Gastrointest Endosc 2010;71:28-34.","journal-title":"Gastrointest Endosc"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1177\/26345161251325874","article-title":"American foregut society white paper report on the use of potassium-competitive acid blockers in the treatment of gastroesophageal reflux disease","volume":"5","author":"Spechler","year":"2025","unstructured":"37. Spechler S, Kolb JM, Dunbar K, et al. American foregut society white paper report on the use of potassium-competitive acid blockers in the treatment of gastroesophageal reflux disease. Foregut 2025;5:195-215.","journal-title":"Foregut"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1053\/j.gastro.2022.09.041","article-title":"Vonoprazan versus lansoprazole for healing and maintenance of healing of erosive esophagitis: a randomized trial","volume":"164","author":"Laine","year":"2023","unstructured":"38. Laine L, DeVault K, Katz P, et al. Vonoprazan versus lansoprazole for healing and maintenance of healing of erosive esophagitis: a randomized trial. Gastroenterology 2023;164:61-71.","journal-title":"Gastroenterology"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1053\/gast.1997.v112.pm9178669","article-title":"Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis","volume":"112","author":"Chiba","year":"1997","unstructured":"39. Chiba N, De Gara CJ, Wilkinson JM, Hunt RH. Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis. Gastroenterology 1997;112:1798-1810.","journal-title":"Gastroenterology"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"40. Qumseya BJ, Bukannan A, Gendy S, et al. Systematic review and meta-analysis of prevalence and risk factors for Barrett's esophagus. Gastrointest Endosc 2019;90:707-717.e1.","DOI":"10.1016\/j.gie.2019.05.030"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"559","DOI":"10.14309\/ajg.0000000000001680","article-title":"Diagnosis and management of Barrett's esophagus: an updated ACG guideline","volume":"117","author":"Shaheen","year":"2022","unstructured":"41. Shaheen NJ, Falk GW, Iyer PG, et al. Diagnosis and management of Barrett's esophagus: an updated ACG guideline. Am J Gastroenterol 2022;117:559-587.","journal-title":"Am J Gastroenterol"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"42. Qumseya B, Sultan S, Bain P, et al. ASGE guideline on screening and surveillance of Barrett's esophagus. Gastrointest Endosc 2019;90:335-359, e2.","DOI":"10.1016\/j.gie.2019.05.012"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"43. Muthusamy VR, Wani S, Gyawali CP, Komanduri S; CGIT Barrett's Esophagus Consensus Conference Participants. AGA clinical practice update on new technology and innovation for surveillance and screening in Barrett's esophagus: expert review. Clin Gastroenterol Hepatol 2022;20:2696-2706, e1.","DOI":"10.1016\/j.cgh.2022.06.003"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/j.1365-2982.2010.01663.x","article-title":"Prolonged, wireless pH-studies have a high diagnostic yield in patients with reflux symptoms and negative 24-h catheter-based pH-studies","volume":"23","author":"Sweis","year":"2011","unstructured":"44. Sweis R, Fox M, Anggiansah A, Wong T. Prolonged, wireless pH-studies have a high diagnostic yield in patients with reflux symptoms and negative 24-h catheter-based pH-studies. Neurogastroenterol Motil 2011;23:419-426.","journal-title":"Neurogastroenterol Motil"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1053\/j.gastro.2021.07.004","article-title":"Value of pH impedance monitoring while on twice-daily proton pump inhibitor therapy to identify need for escalation of reflux management","volume":"161","author":"Gyawali","year":"2021","unstructured":"45. Gyawali CP, Tutuian R, Zerbib F, et al. Value of pH impedance monitoring while on twice-daily proton pump inhibitor therapy to identify need for escalation of reflux management. Gastroenterology 2021;161:1412-1422.","journal-title":"Gastroenterology"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1097\/SLA.0000000000006297","article-title":"The role of high-resolution manometry before and following antireflux surgery: the Padova consensus","volume":"281","author":"Salvador","year":"2025","unstructured":"46. Salvador R, Pandolfino JE, Costantini M, et al. The role of high-resolution manometry before and following antireflux surgery: the Padova consensus. Ann Surg 2025;281:124-135.","journal-title":"Ann Surg"},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"47. Yadlapati R, Kahrilas PJ, Fox MR, et al. Esophageal motility disorders on high-resolution manometry: Chicago classification version 4.0\u00a9. Neurogastroenterol Motil 2021;33:e14058.","DOI":"10.1111\/nmo.14053"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"48. Gyawali CP, Zerbib F, Bhatia S, et al. Chicago classification update (V4.0): technical review on diagnostic criteria for ineffective esophageal motility and absent contractility. Neurogastroenterol Motil 2021;33:e14134.","DOI":"10.1111\/nmo.14134"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.1007\/s00464-011-1646-9","article-title":"Value of preoperative esophageal function studies before laparoscopic antireflux surgery","volume":"25","author":"Chan","year":"2011","unstructured":"49. Chan WW, Haroian LR, Gyawali CP. Value of preoperative esophageal function studies before laparoscopic antireflux surgery. Surg Endosc 2011;25:2943-2949.","journal-title":"Surg Endosc"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/MCG.0000000000002133","article-title":"Reflux seen on a barium swallow is not a substitute for ambulatory reflux monitoring in symptomatic patients","volume":"60","author":"Bhardwaj","year":"2026","unstructured":"50. Bhardwaj R, Davis TA, Franz A, et al. Reflux seen on a barium swallow is not a substitute for ambulatory reflux monitoring in symptomatic patients. J Clin Gastroenterol 2026;60:129-135.","journal-title":"J Clin Gastroenterol"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1136\/gut.45.2.172","article-title":"Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification","volume":"45","author":"Lundell","year":"1999","unstructured":"51. Lundell LR, Dent J, Bennett JR, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999;45:172-180.","journal-title":"Gut"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1136\/gutjnl-2020-323798","article-title":"Validation of the Lyon classification for GORD diagnosis: acid exposure time assessed by prolonged wireless pH monitoring in healthy controls and patients with erosive oesophagitis","volume":"70","author":"Rusu","year":"2021","unstructured":"52. Rusu RI, Fox MR, Tucker E, et al. Validation of the Lyon classification for GORD diagnosis: acid exposure time assessed by prolonged wireless pH monitoring in healthy controls and patients with erosive oesophagitis. Gut 2021;70:2230-2237.","journal-title":"Gut"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1080\/17474124.2022.2134115","article-title":"Induction and maintenance of healing in erosive esophagitis in the United States","volume":"16","author":"Yadlapati","year":"2022","unstructured":"53. Yadlapati R, Hubscher E, Pelletier C, Jacob R, Brackley A, Shah S. Induction and maintenance of healing in erosive esophagitis in the United States. Expert Rev Gastroenterol Hepatol 2022;16: 967-980.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1001\/jama.2016.5657","article-title":"Association of acute gastroesophageal reflux disease with esophageal histologic changes","volume":"315","author":"Dunbar","year":"2016","unstructured":"54. Dunbar KB, Agoston AT, Odze RD, et al. Association of acute gastroesophageal reflux disease with esophageal histologic changes. JAMA 2016;315:2104-2112.","journal-title":"JAMA"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"794","DOI":"10.14309\/ajg.0000000000002173","article-title":"Ambulatory pH-impedance findings confirm that grade B esophagitis provides objective diagnosis of gastroesophageal reflux disease","volume":"118","author":"Visaggi","year":"2023","unstructured":"55. Visaggi P, Del Corso G, Gyawali CP, et al. Ambulatory pH-impedance findings confirm that grade B esophagitis provides objective diagnosis of gastroesophageal reflux disease. Am J Gastroenterol 2023;118:794-801.","journal-title":"Am J Gastroenterol"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1053\/gast.1996.v111.pm8698230","article-title":"The endoscopic assessment of esophagitis: a progress report on observer agreement","volume":"111","author":"Armstrong","year":"1996","unstructured":"56. Armstrong D, Bennett JR, Blum AL, et al. The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology 1996;111:85-92.","journal-title":"Gastroenterology"},{"key":"ref56","doi-asserted-by":"publisher","unstructured":"57. Spechler SJ, Laine L, DeVault KR, Nabulsi A, Hunt B, Katz P. Comparison of Los Angeles grades of erosive esophagitis scored by local investigators vs central adjudicators in a clinical trial. Clin Gastroenterol Hepatol 2024;22:2526-2528.e1.","DOI":"10.1016\/j.cgh.2024.05.007"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.cgh.2025.02.027","article-title":"Prolonged wireless pH monitoring: how long is long enough","volume":"24","author":"WW","year":"2026","unstructured":"58. Chan WW, Gyawali CP. Prolonged wireless pH monitoring: how long is long enough. Clin Gastroenterol Hepatol 2026;24:306-308.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1007\/s10620-009-0742-3","article-title":"Prevalence of complicated gastroesophageal reflux disease and Barrett's esophagus among racial groups in a multi-center consortium","volume":"54","author":"Wang","year":"2009","unstructured":"59. Wang A, Mattek NC, Holub JL, Lieberman DA, Eisen GM. Prevalence of complicated gastroesophageal reflux disease and Barrett's esophagus among racial groups in a multi-center consortium. Dig Dis Sci 2009;54:964-971.","journal-title":"Dig Dis Sci"},{"key":"ref59","unstructured":"60. Sonnenberg A, El-Serag HB. Clinical epidemiology and natural history of gastroesophageal reflux disease. Yale J Biol Med 1999; 72:81-92."},{"key":"ref60","doi-asserted-by":"publisher","first-page":"967","DOI":"10.14309\/ajg.0000000000000655","article-title":"Management of peptic strictures","volume":"115","author":"Desai","year":"2020","unstructured":"61. Desai M, Hamade N, Sharma P. Management of peptic strictures. Am J Gastroenterol 2020;115:967-970.","journal-title":"Am J Gastroenterol"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1046\/j.1365-2036.1999.00582.x","article-title":"Omeprazole therapy decreases the need for dilatation of peptic oesophageal strictures","volume":"13","author":"Barbezat","year":"1999","unstructured":"62. Barbezat GO, Schlup M, Lubcke R. Omeprazole therapy decreases the need for dilatation of peptic oesophageal strictures. Aliment Pharmacol Ther 1999;13:1041-1045.","journal-title":"Aliment Pharmacol Ther"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1007\/s10620-018-5070-z","article-title":"Clinical guidelines update on the diagnosis and management of Barrett's esophagus","volume":"63","author":"Clermont","year":"2018","unstructured":"63. Clermont M, Falk GW. Clinical guidelines update on the diagnosis and management of Barrett's esophagus. Dig Dis Sci 2018;63:2122-2128.","journal-title":"Dig Dis Sci"},{"key":"ref63","doi-asserted-by":"publisher","unstructured":"64. Savarino E, Zentilin P, Frazzoni M, et al. Characteristics of gastro-esophageal reflux episodes in Barrett's esophagus, erosive esophagitis and healthy volunteers. Neurogastroenterol Motil 2010;22:1061-e280.","DOI":"10.1111\/j.1365-2982.2010.01536.x"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1046\/j.1365-2036.2003.01768.x","article-title":"Different patterns of oesophageal acid exposure distinguish complicated reflux disease from either erosive reflux oesophagitis or non-erosive reflux disease","volume":"18","author":"Frazzoni","year":"2003","unstructured":"65. Frazzoni M, De Micheli E, Savarino V. Different patterns of oesophageal acid exposure distinguish complicated reflux disease from either erosive reflux oesophagitis or non-erosive reflux disease. Aliment Pharmacol Ther 2003;18:1091-1098.","journal-title":"Aliment Pharmacol Ther"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1111\/j.1572-0241.1998.00276.x","article-title":"Esophageal manometry and ambulatory 24-hour pH monitoring in patients with short and long segment Barrett's esophagus","volume":"93","author":"Loughney","year":"1998","unstructured":"66. Loughney T, Maydonovitch CL, Wong RK. Esophageal manometry and ambulatory 24-hour pH monitoring in patients with short and long segment Barrett's esophagus. Am J Gastroenterol 1998; 93:916-919.","journal-title":"Am J Gastroenterol"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1136\/gut.48.3.310","article-title":"Correlation of oesophageal acid exposure with Barrett's oesophagus length","volume":"48","author":"Fass","year":"2001","unstructured":"67. Fass R, Hell RW, Garewal HS, et al. Correlation of oesophageal acid exposure with Barrett's oesophagus length. Gut 2001;48: 310-313.","journal-title":"Gut"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1038\/ajg.2011.130","article-title":"Epidemiology and natural history of intestinal metaplasia of the gastroesophageal junction and Barrett's esophagus: a population-based study","volume":"106","author":"Jung","year":"2011","unstructured":"68. Jung KW, Talley NJ, Romero Y, et al. Epidemiology and natural history of intestinal metaplasia of the gastroesophageal junction and Barrett's esophagus: a population-based study. Am J Gastroenterol 2011;106:1447-1455.","journal-title":"Am J Gastroenterol"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1053\/j.gastro.2016.12.005","article-title":"Low risk of highgrade dysplasia or esophageal adenocarcinoma among patients with Barrett's esophagus less than 1 cm (irregular Z line) within 5 years of index endoscopy","volume":"152","author":"Thota","year":"2017","unstructured":"69. Thota PN, Vennalaganti P, Vennelaganti S, et al. Low risk of highgrade dysplasia or esophageal adenocarcinoma among patients with Barrett's esophagus less than 1 cm (irregular Z line) within 5 years of index endoscopy. Gastroenterology 2017;152:987-992.","journal-title":"Gastroenterology"},{"key":"ref69","doi-asserted-by":"publisher","unstructured":"70. Weijenborg PW, Cremonini F, Smout AJ, Bredenoord AJ. PPI therapy is equally effective in well-defined non-erosive reflux disease and in reflux esophagitis: a meta-analysis. Neurogastroenterol Motil 2012;24:747-757, e350.","DOI":"10.1111\/j.1365-2982.2012.01888.x"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.14309\/ajg.0000000000003383","article-title":"High risk of persistence and risk of dysplasia after diagnosis of ultrashort Barrett's esophagus","volume":"120","author":"Skef","year":"2025","unstructured":"71. Skef W, Haydel J, Rao A, et al. High risk of persistence and risk of dysplasia after diagnosis of ultrashort Barrett's esophagus. Am J Gastroenterol 2025;120:2520-2528.","journal-title":"Am J Gastroenterol"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/nmo.13067","article-title":"Ambulatory reflux monitoring for diagnosis of gastro-esophageal reflux disease: update of the Porto consensus and recommendations from an international consensus group","volume":"29","author":"Roman","year":"2017","unstructured":"72. Roman S, Gyawali CP, Savarino E, et al. Ambulatory reflux monitoring for diagnosis of gastro-esophageal reflux disease: update of the Porto consensus and recommendations from an international consensus group. Neurogastroenterol Motil 2017;29:1-15.","journal-title":"Neurogastroenterol Motil"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1007\/BF01535789","article-title":"Reproducibility and variability of pH parameters","volume":"33","author":"Wiener","year":"1988","unstructured":"73. Wiener GJ, Morgan TM, Copper JB, et al. Ambulatory 24-hour esophageal pH monitoring. Reproducibility and variability of pH parameters. Dig Dis Sci 1988;33:1127-1133.","journal-title":"Dig Dis Sci"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/0016-5085(87)90318-0","article-title":"Optimal thresholds, sensitivity, and specificity of long-term pH-metry for the detection of gastroesophageal reflux disease","volume":"93","author":"Schindlbeck","year":"1987","unstructured":"74. Schindlbeck NE, Heinrich C, K\u00f6nig A, Dendorfer A, Pace F, M\u00fcller-Lissner SA. Optimal thresholds, sensitivity, and specificity of long-term pH-metry for the detection of gastroesophageal reflux disease. Gastroenterology 1987;93:85-90.","journal-title":"Gastroenterology"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1007\/BF01536258","article-title":"Physiological gastroesophageal reflux and esophageal motor activity studied with a new system for 24-hour recording and automated analysis","volume":"34","author":"Smout","year":"1989","unstructured":"75. Smout AJ, Breedijk M, van der Zouw C, Akkermans LM. Physiological gastroesophageal reflux and esophageal motor activity studied with a new system for 24-hour recording and automated analysis. Dig Dis Sci 1989;34:372-378.","journal-title":"Dig Dis Sci"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.cgh.2014.08.029","article-title":"Parameters on esophageal pH-impedance monitoring that predict outcomes of patients with gastroesophageal reflux disease","volume":"13","author":"Patel","year":"2015","unstructured":"76. Patel A, Sayuk GS, Gyawali CP. Parameters on esophageal pH-impedance monitoring that predict outcomes of patients with gastroesophageal reflux disease. Clin Gastroenterol Hepatol 2015; 13:884-891.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.cgh.2012.10.041","article-title":"Normal values of pharyngeal and esophageal 24-hour pH impedance in individuals on and off therapy and interobserver reproducibility","volume":"11","author":"Zerbib","year":"2013","unstructured":"77. Zerbib F, Roman S, Bruley Des Varannes S, et al. Normal values of pharyngeal and esophageal 24-hour pH impedance in individuals on and off therapy and interobserver reproducibility. Clin Gastroenterol Hepatol 2013;11:366-372.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1111\/j.1572-0241.2004.04172.x","article-title":"Twenty-four hour ambulatory simultaneous impedance and pH monitoring: a multicenter report of normal values from 60 healthy volunteers","volume":"99","author":"Shay","year":"2004","unstructured":"78. Shay S, Tutuian R, Sifrim D, et al. Twenty-four hour ambulatory simultaneous impedance and pH monitoring: a multicenter report of normal values from 60 healthy volunteers. Am J Gastroenterol 2004;99:1037-1043.","journal-title":"Am J Gastroenterol"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1111\/j.1365-2036.2005.02677.x","article-title":"Normal values and day-to-day variability of 24-h ambulatory oesophageal impedance-pH monitoring in a Belgian-French cohort of healthy subjects","volume":"22","author":"Zerbib","year":"2005","unstructured":"79. Zerbib F, des Varannes SB, Roman S, et al. Normal values and day-to-day variability of 24-h ambulatory oesophageal impedance-pH monitoring in a Belgian-French cohort of healthy subjects. Aliment Pharmacol Ther 2005;22:1011-1021.","journal-title":"Aliment Pharmacol Ther"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"453","DOI":"10.5056\/jnm21077","article-title":"2020 Seoul consensus on the diagnosis and management of gastroesophageal reflux disease","volume":"27","author":"Jung","year":"2021","unstructured":"80. Jung HK, Tae CH, Song KH, et al. 2020 Seoul consensus on the diagnosis and management of gastroesophageal reflux disease. J Neurogastroenterol Motil 2021;27:453-481.","journal-title":"J Neurogastroenterol Motil"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1136\/gutjnl-2020-322627","article-title":"Normal values and regional differences in oesophageal impedance-pH metrics: a consensus analysis of impedance-pH studies from around the world","volume":"70","author":"Sifrim","year":"2021","unstructured":"81. Sifrim D, Roman S, Savarino E, et al. Normal values and regional differences in oesophageal impedance-pH metrics: a consensus analysis of impedance-pH studies from around the world. Gut 2021;70:1441-1449.","journal-title":"Gut"},{"key":"ref81","doi-asserted-by":"publisher","unstructured":"82. Yadlapati R, Masihi M, Gyawali CP, et al. Ambulatory reflux monitoring guides proton pump inhibitor discontinuation in patients with gastroesophageal reflux symptoms: a clinical trial. Gastroenterology 2021;160:174-182, e1.","DOI":"10.1053\/j.gastro.2020.09.013"},{"key":"ref82","doi-asserted-by":"publisher","unstructured":"83. Jodorkovsky D, Katzka DA, Gyawali CP. A perspective on the clinical relevance of weak or nonacid reflux. Neurogastroenterol Motil 2023;35:e14671.","DOI":"10.1111\/nmo.14671"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1136\/gutjnl-2020-321395","article-title":"Number of reflux episodes on pH-impedance monitoring associates with improved symptom outcome and treatment satisfaction in gastro-oesophageal reflux disease (GERD) patients with regurgitation","volume":"70","author":"Rogers","year":"2021","unstructured":"84. Rogers BD, Valdovinos LR, Crowell MD, Bell R, Vela MF, Gyawali CP. Number of reflux episodes on pH-impedance monitoring associates with improved symptom outcome and treatment satisfaction in gastro-oesophageal reflux disease (GERD) patients with regurgitation. Gut 2021;70:450-455.","journal-title":"Gut"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1111\/apt.16838","article-title":"Applying Lyon consensus criteria in the work-up of patients with proton pump inhibitory-refractory heartburn","volume":"55","author":"Frazzoni","year":"2022","unstructured":"85. Frazzoni M, Frazzoni L, Ribolsi M, et al. Applying Lyon consensus criteria in the work-up of patients with proton pump inhibitory-refractory heartburn. Aliment Pharmacol Ther 2022;55:1423-1430.","journal-title":"Aliment Pharmacol Ther"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.cgh.2015.06.026","article-title":"Analyses of the post-reflux swallow-induced peristaltic wave index and nocturnal baseline impedance parameters increase the diagnostic yield of impedance-pH monitoring of patients with reflux disease","volume":"14","author":"Frazzoni","year":"2016","unstructured":"86. Frazzoni M, Savarino E, de Bortoli N, et al. Analyses of the post-reflux swallow-induced peristaltic wave index and nocturnal baseline impedance parameters increase the diagnostic yield of impedance-pH monitoring of patients with reflux disease. Clin Gastroenterol Hepatol 2016;14:40-46.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1111\/apt.13777","article-title":"Distal mean nocturnal baseline impedance on pH-impedance monitoring predicts reflux burden and symptomatic outcome in gastro-oesophageal reflux disease","volume":"44","author":"Patel","year":"2016","unstructured":"87. Patel A, Wang D, Sainani N, Sayuk GS, Gyawali CP. Distal mean nocturnal baseline impedance on pH-impedance monitoring predicts reflux burden and symptomatic outcome in gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2016;44:890-898.","journal-title":"Aliment Pharmacol Ther"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"43","DOI":"10.5056\/jnm17032","article-title":"Esophageal baseline impedance reflects mucosal integrity and predicts symptomatic outcome with proton pump inhibitor treatment","volume":"24","author":"Xie","year":"2018","unstructured":"88. Xie C, Sifrim D, Li Y, Chen M, Xiao Y. Esophageal baseline impedance reflects mucosal integrity and predicts symptomatic outcome with proton pump inhibitor treatment. J Neurogastroenterol Motil 2018;24:43-50.","journal-title":"J Neurogastroenterol Motil"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.cgh.2019.05.044","article-title":"Mean nocturnal baseline impedance correlates with symptom outcome when acid exposure time is inconclusive on esophageal reflux monitoring","volume":"18","author":"Rengarajan","year":"2020","unstructured":"89. Rengarajan A, Savarino E, Della Coletta M, Ghisa M, Patel A, Gyawali CP. Mean nocturnal baseline impedance correlates with symptom outcome when acid exposure time is inconclusive on esophageal reflux monitoring. Clin Gastroenterol Hepatol 2020; 18:589-595.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1136\/gut.2004.054981","article-title":"Symptom association probability and symptom sensitivity index: preferable but still suboptimal predictors of response to high dose omeprazole","volume":"54","author":"Taghavi","year":"2005","unstructured":"90. Taghavi SA, Ghasedi M, Saberi-Firoozi M, et al. Symptom association probability and symptom sensitivity index: preferable but still suboptimal predictors of response to high dose omeprazole. Gut 2005;54:1067-1071.","journal-title":"Gut"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1038\/ajg.2009.646","article-title":"Abnormal GERD parameters on ambulatory pH monitoring predict therapeutic success in noncardiac chest pain","volume":"105","author":"Kushnir","year":"2010","unstructured":"91. Kushnir VM, Sayuk GS, Gyawali CP. Abnormal GERD parameters on ambulatory pH monitoring predict therapeutic success in noncardiac chest pain. Am J Gastroenterol 2010;105:1032-1038.","journal-title":"Am J Gastroenterol"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.cgh.2011.07.009","article-title":"Caution about overinterpretation of symptom indexes in reflux monitoring for refractory gastroesophageal reflux disease","volume":"9","author":"Slaughter","year":"2011","unstructured":"92. Slaughter JC, Goutte M, Rymer JA, et al. Caution about overinterpretation of symptom indexes in reflux monitoring for refractory gastroesophageal reflux disease. Clin Gastroenterol Hepatol 2011;9:868-874.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s00535-012-0672-2","article-title":"Microscopic esophagitis distinguishes patients with non-erosive reflux disease from those with functional heartburn","volume":"48","author":"Savarino","year":"2013","unstructured":"93. Savarino E, Zentilin P, Mastracci L, et al. Microscopic esophagitis distinguishes patients with non-erosive reflux disease from those with functional heartburn. J Gastroenterol 2013;48:473-482.","journal-title":"J Gastroenterol"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/ajg.2010.476","article-title":"functional heartburn","volume":"106","author":"Vela","year":"2011","unstructured":"94. Vela MF, Craft BM, Sharma N, Freeman J, Hazen-Martin D. Refractory heartburn: comparison of intercellular space diameter in documented GERD vs. functional heartburn. Am J Gastroenterol 2011;106:844-850.","journal-title":"Am J Gastroenterol"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1136\/gut.39.2.151","article-title":"Diagnostic value of histology in non-erosive gastro-oesophageal reflux disease","volume":"39","author":"Schindlbeck","year":"1996","unstructured":"95. Schindlbeck NE, Wiebecke B, Klauser AG, Voderholzer WA, M\u00fcller-Lissner SA. Diagnostic value of histology in non-erosive gastro-oesophageal reflux disease. Gut 1996;39:151-154.","journal-title":"Gut"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.dld.2025.01.182","article-title":"Mucosal integrity and acid sensitivity predict proton pump inhibitor response in patients with heartburn and normal acid exposure","volume":"57","author":"Wong","year":"2025","unstructured":"96. Wong MW, Yi CH, Liu TT, et al. Mucosal integrity and acid sensitivity predict proton pump inhibitor response in patients with heartburn and normal acid exposure. Dig Liver Dis 2025;57:842-848.","journal-title":"Dig Liver Dis"},{"key":"ref96","doi-asserted-by":"publisher","unstructured":"97. Moshiree B, Drossman D, Shaukat A. AGA clinical practice update on evaluation and management of belching, abdominal bloating, and distention: expert review. Gastroenterology 2023;165:791-800, e3.","DOI":"10.1053\/j.gastro.2023.04.039"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1097\/MCG.0b013e3181bd885e","article-title":"Effect of sleep on excessive belching: a 24-hour impedance-pH study","volume":"44","author":"Karamanolis","year":"2010","unstructured":"98. Karamanolis G, Triantafyllou K, Tsiamoulos Z, et al. Effect of sleep on excessive belching: a 24-hour impedance-pH study. J Clin Gastroenterol 2010;44:332-334.","journal-title":"J Clin Gastroenterol"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"398","DOI":"10.5056\/jnm15002","article-title":"Supragastric belching: prevalence and association with gastroesophageal reflux disease and esophageal hypomotility","volume":"21","author":"Koukias","year":"2015","unstructured":"99. Koukias N, Woodland P, Yazaki E, Sifrim D. Supragastric belching: prevalence and association with gastroesophageal reflux disease and esophageal hypomotility. J Neurogastroenterol Motil 2015;21:398-403.","journal-title":"J Neurogastroenterol Motil"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"231","DOI":"10.5056\/jnm20114","article-title":"Characteristics of symptomatic belching in patients with belching disorder and patients who exhibit gastroesophageal reflux disease with belching","volume":"27","author":"Jeong","year":"2021","unstructured":"100. Jeong SO, Lee JS, Lee TH, et al. Characteristics of symptomatic belching in patients with belching disorder and patients who exhibit gastroesophageal reflux disease with belching. J Neurogastroenterol Motil 2021;27:231-239.","journal-title":"J Neurogastroenterol Motil"},{"key":"ref100","doi-asserted-by":"publisher","unstructured":"101. Yadlapati R, Tye M, Roman S, Kahrilas PJ, Ritter K, Pandolfino JE. Postprandial high-resolution impedance manometry identifies mechanisms of nonresponse to proton pump inhibitors. Clin Gastroenterol Hepatol 2018;16:211-218, e1.","DOI":"10.1016\/j.cgh.2017.09.011"},{"key":"ref101","doi-asserted-by":"publisher","unstructured":"102. Hurtte E, Rogers BD, Richards C, Gyawali CP. The clinical value of psycho-gastroenterological interventions for functional esophageal symptoms. Neurogastroenterol Motil 2022;34:e14315.","DOI":"10.1111\/nmo.14315"},{"key":"ref102","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1053\/j.gastro.2016.02.011","article-title":"Gastroduodenal disorders","volume":"150","author":"Stanghellini","year":"2016","unstructured":"103. Stanghellini V, Chan FK, Hasler WL, et al. Gastroduodenal disorders. Gastroenterology 2016;150:1380-1392.","journal-title":"Gastroenterology"},{"key":"ref103","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/ajg.2013.428","article-title":"Objective manometric criteria for the rumination syndrome","volume":"109","author":"Kessing","year":"2014","unstructured":"104. Kessing BF, Bredenoord AJ, Smout AJ. Objective manometric criteria for the rumination syndrome. Am J Gastroenterol 2014; 109:52-59.","journal-title":"Am J Gastroenterol"},{"key":"ref104","doi-asserted-by":"publisher","unstructured":"105. Barba E, Burri E, Accarino A, et al. Biofeedback-guided control of abdominothoracic muscular activity reduces regurgitation episodes in patients with rumination. Clin Gastroenterol Hepatol 2015;13:100-106, e1.","DOI":"10.1016\/j.cgh.2014.04.018"},{"key":"ref105","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1111\/nmo.12737","article-title":"Diaphragmatic breathing for rumination syndrome: efficacy and mechanisms of action","volume":"28","author":"Halland","year":"2016","unstructured":"106. Halland M, Parthasarathy G, Bharucha AE, Katzka DA. Diaphragmatic breathing for rumination syndrome: efficacy and mechanisms of action. Neurogastroenterol Motil 2016;28:384-391.","journal-title":"Neurogastroenterol Motil"},{"key":"ref106","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1111\/j.1365-2036.2012.05070.x","article-title":"Supragastric belches are the main determinants of troublesome belching symptoms in patients with gastro-oesophageal reflux disease","volume":"35","author":"Kessing","year":"2012","unstructured":"107. Kessing BF, Bredenoord AJ, Velosa M, Smout AJ. Supragastric belches are the main determinants of troublesome belching symptoms in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2012;35:1073-1079.","journal-title":"Aliment Pharmacol Ther"},{"key":"ref107","doi-asserted-by":"publisher","unstructured":"108. Kahrilas PJ, Keefer L, Pandolfino JE. Patients with refractory reflux symptoms: what do they have and how should they be managed? Neurogastroenterol Motil 2015;27:1195-1201.","DOI":"10.1111\/nmo.12644"},{"key":"ref108","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1053\/j.gastro.2023.06.019","article-title":"Psychological processes, not physiological parameters, are most important contributors to symptom severity in patients with refractory heartburn\/regurgitation symptoms","volume":"165","author":"Guadagnoli","year":"2023","unstructured":"109. Guadagnoli L, Geeraerts A, Geysen H, et al. Psychological processes, not physiological parameters, are most important contributors to symptom severity in patients with refractory heartburn\/regurgitation symptoms. Gastroenterology 2023;165:848-860.","journal-title":"Gastroenterology"},{"key":"ref109","doi-asserted-by":"publisher","first-page":"395","DOI":"10.2147\/JPR.S146916","article-title":"Does pain hypervigilance further impact the lack of habituation to pain in individuals with chronic pain? A cross-sectional pain ERP study","volume":"11","author":"Vossen","year":"2018","unstructured":"110. Vossen CJ, Luijcks R, van Os J, Joosten EA, Lousberg R. Does pain hypervigilance further impact the lack of habituation to pain in individuals with chronic pain? A cross-sectional pain ERP study. J Pain Res 2018;11:395-405.","journal-title":"J Pain Res"},{"key":"ref110","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1111\/apt.14605","article-title":"Validation of the oesophageal hypervigilance and anxiety scale for chronic oesophageal disease","volume":"47","author":"Taft","year":"2018","unstructured":"111. Taft TH, Triggs JR, Carlson DA, et al. Validation of the oesophageal hypervigilance and anxiety scale for chronic oesophageal disease. Aliment Pharmacol Ther 2018;47:1270-1277.","journal-title":"Aliment Pharmacol Ther"},{"key":"ref111","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1111\/apt.16561","article-title":"Oesophageal hypervigilance and visceral anxiety relate to reflux symptom severity and psychological distress but not to acid reflux parameters","volume":"54","author":"Wong","year":"2021","unstructured":"112. Wong MW, Liu TT, Yi CH, et al. Oesophageal hypervigilance and visceral anxiety relate to reflux symptom severity and psychological distress but not to acid reflux parameters. Aliment Pharmacol Ther 2021;54:923-930.","journal-title":"Aliment Pharmacol Ther"},{"key":"ref112","doi-asserted-by":"publisher","first-page":"786","DOI":"10.14309\/ajg.0000000000002151","article-title":"Esophageal hypervigilance and visceral anxiety contribute to symptom severity of laryngopharyngeal reflux","volume":"118","author":"Wong","year":"2023","unstructured":"113. Wong MW, Hsiao SH, Wang JH, et al. Esophageal hypervigilance and visceral anxiety contribute to symptom severity of laryngopharyngeal reflux. Am J Gastroenterol 2023;118:786-793.","journal-title":"Am J Gastroenterol"},{"key":"ref113","doi-asserted-by":"publisher","first-page":"7656","DOI":"10.1007\/s00464-022-09081-5","article-title":"Finding relief for the self-conscious esophagus: laparoscopic anti-reflux surgery and the esophageal hypersensitivity and anxiety scale","volume":"36","author":"Hill","year":"2022","unstructured":"114. Hill C, Crijns T, Nofal Y, et al. Finding relief for the self-conscious esophagus: laparoscopic anti-reflux surgery and the esophageal hypersensitivity and anxiety scale. Surg Endosc 2022;36:7656-7663.","journal-title":"Surg Endosc"},{"key":"ref114","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1080\/00029157.2015.1025355","article-title":"Hypnotherapy for esophageal disorders","volume":"58","author":"ME","year":"2015","unstructured":"115. Riehl ME, Keefer L. Hypnotherapy for esophageal disorders. Am J Clin Hypn 2015;58:22-33.","journal-title":"Am J Clin Hypn"},{"key":"ref115","doi-asserted-by":"publisher","unstructured":"116. Guadagnoli L, Yadlapati R, Pandolfino J, et al. Behavioral therapy for functional heartburn: recommendation statements. Clin Gastroenterol Hepatol 2024;22:1709-1718, e3.","DOI":"10.1016\/j.cgh.2024.03.004"}],"container-title":["Experimental and Clinical Transplantation"],"original-title":[],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T06:27:54Z","timestamp":1785306474000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ectrx.org\/detail\/supplement\/2026\/24\/6\/2\/78\/0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":116,"journal-issue":{"issue":"Supp 2","published-print":{"date-parts":[[2026,7]]}},"URL":"https:\/\/doi.org\/10.6002\/ect.mesot2025.o25","relation":{},"ISSN":["1304-0855","2146-8427"],"issn-type":[{"value":"1304-0855","type":"print"},{"value":"2146-8427","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]}}}